Prevail Stock Price, News & Analysis

PRVL NASDAQ

Company Description

Prevail (NASDAQ: PRVL) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

PRVL stock has gained 25.8% over the past year.

This page provides a comprehensive overview of PRVL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+25.75%

Performance 1 year

$0.0

Market Cap

34.2M

Shares outstanding

Prevail (PRVL) stock. Over the past 12 months, the stock has gained 25.8%.

Latest News

View All

January 22, 2021

—

Lilly Completes Acquisition of Prevail Therapeutics

acquisition

December 11, 2020

+10.18%

Prevail Therapeutics Announces First Patient Dosed in Phase 1/2 PROCLAIM Clinical Trial Evaluating PR006 for the Treatment of Frontotemporal Dementia Patients with GRN Mutations

clinical trial

November 30, 2020

+2.39%

Prevail Therapeutics Receives European Commission Orphan Designation for PR006 for the Treatment of Frontotemporal Dementia

November 19, 2020

+4.02%

Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001

November 13, 2020

-0.41%

Prevail Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights

earnings

November 10, 2020

+3.01%

Prevail Therapeutics to Present at Upcoming Investor Conferences

conferences

Prevail has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial, earnings, conferences, fda approval. View all PRVL news →

SEC Filings

View All

No SEC filings available for PRVL.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

PRVL Company Profile & Sector Positioning

Prevail (PRVL) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.